Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum

ISSN： 0785-3890

Source： Annals of Medicine, Vol.37, Iss.4, 2005-06, pp. : 250-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 238-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self-monitoring of blood glucose and glycaemic control in type 2 diabetes

By Tengblad Anders Grodzinsky Ewa Lindström Kjell Mölstad Sigvard Borgquist Lars Östgren Carl Johan

Scandinavian Journal of Primary Health Care, Vol. 25, Iss. 3, 2007-01 ,pp. : 140-146

Informa Healthcare

Access to resources Recommend Favorite

What is the best approach to glycaemic control in patients with type 2 diabetes?

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 105-106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type 2 diabetes, thiazolidinediones, and cardiovascular risk

By Taylor Clare Hobbs FD Richard

British Journal of General Practice, Vol. 59, Iss. 564, 2009-07 ,pp. : 520-524

Royal College of General Practitioners

Access to resources Recommend Favorite

A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 681-688

John Wiley & Sons Inc

Access to resources Recommend Favorite